Walvax Biotechnology Co (SZSE:300142) Long-Term Debt : ¥435 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Long-Term Debt?

Walvax Biotechnology Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥435 Mil.

Walvax Biotechnology Co's quarterly Long-Term Debt increased from Sep. 2023 (¥417 Mil) to Dec. 2023 (¥435 Mil) but then declined from Dec. 2023 (¥435 Mil) to Mar. 2024 (¥435 Mil).

Walvax Biotechnology Co's annual Long-Term Debt increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥314 Mil) and increased from Dec. 2022 (¥314 Mil) to Dec. 2023 (¥435 Mil).

Walvax Biotechnology Co Long-Term Debt Historical Data

The historical data trend for Walvax Biotechnology Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Long-Term Debt Chart

Walvax Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

314.24

434.90

Walvax Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															359.77	371.37	416.71	434.90	434.60

Walvax Biotechnology Co (SZSE:300142) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Walvax Biotechnology Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Walvax Biotechnology Co (SZSE:300142) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106

Website

http://www.walvax.com

Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.

Executives

Wu Yun Yan	Executives
Zhao Jin Long	Executives
Yao Wei	Executives
Zhou Hua	Executives
Shi Jing	Executives
Jiang Run Sheng	Directors, executives
Gong Sun Qing	Executives
	Executives
Yuan Lin	Executives
Fang Guo Liang	Executives
Li Yun Chun	Director
Huang Zhen	Director
Zhang Li	Secretary Dong
Yang Hong Wei	Supervisors
Xu Ke Ren	Executives

Walvax Biotechnology Co (SZSE:300142) Headlines

No Headlines